Home
>
National Drug Code (NDC)
>
COUMADIN
COUMADIN - 0590-0324-35 - (warfarin sodium)
Drug Information of COUMADIN
| Product NDC: | 0590-0324 |
| Proprietary Name: | COUMADIN |
| Non Proprietary Name: | warfarin sodium |
| Active Ingredient(s): | 2 mg/mL & nbsp; warfarin sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of COUMADIN
| Product NDC: | 0590-0324 |
| Labeler Name: | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009218 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090101 |
Package Information of COUMADIN
| Package NDC: | 0590-0324-35 |
| Package Description: | 6 CARTON in 1 CARTON (0590-0324-35) > 1 VIAL in 1 CARTON > 2.5 mL in 1 VIAL |
NDC Information of COUMADIN
| NDC Code | 0590-0324-35 |
| Proprietary Name | COUMADIN |
| Package Description | 6 CARTON in 1 CARTON (0590-0324-35) > 1 VIAL in 1 CARTON > 2.5 mL in 1 VIAL |
| Product NDC | 0590-0324 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | warfarin sodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090101 |
| Marketing Category Name | NDA |
| Labeler Name | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company |
| Substance Name | WARFARIN SODIUM |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA] |
